Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

ClinicalTrials.gov ID: NCT00596583

Public ClinicalTrials.gov record NCT00596583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AQNA-DY001: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to test the hypothesis that DYME is safe and effective as a drug to facilitate continuous curvilinear capsulorhexis (CCC) by selectively staining the anterior capsule. Secondary objectives are to compare the safety and effectiveness of DYME to that of a smaller dose of the same API.

Study identification

NCT ID
NCT00596583
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aqumen Biopharmaceuticals, N.A.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
May 2008 (Actual)
Completion
May 2008 (Actual)
Last update posted
Mar 2, 2009

2007 – 2008

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
McDonald Eye Associates Fayetteville Arkansas 72703 —
Peace Laser Eye Center Inglewood California 90301 —
Capitol City Surgery Center Sacramento California 95815 —
The Eye Institute of West Florida Largo Florida 33770 —
Center for Excellence in Eye Care Miami Florida 33176 —
Eye Surgeons of Indiana Indianapolis Indiana 46256 —
Silverstein Eye Centers Kansas City Missouri 64133 —
St. John's Clinic Eye Specialists Springfield Missouri 65804 —
Ballas Surgery Center St Louis Missouri 63141 —
Wills Eye Surgery Center Cherry Hill New Jersey 08002 —
Brar-Parekh Eye Associates Woodland Park New Jersey 07424 —
Island Eye Surgicenter Carle Place New York 11514 —
The Ohio State University Hospital Columbus Ohio 43210 —
Eye Care Specialists Kingston Pennsylvania 18704 —
Wills Eye Surgery Center Philadelphia Pennsylvania 19107 —
Wills Surgery Center Philadelphia Pennsylvania 19145 —
SMDV Surgery Center Madison Wisconsin 53715 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00596583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2009 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00596583 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →